GlassScriptPhysician profile
Rhonda Williams
NPI 1194225904
$8,252.44
in general payments reported to CMS, 2019-2025
35 companies · $357 in 2025
The $357 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,665 · 2022: $1,747 · 2023: $2,570 · 2024: $1,912 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,775 · Education: $64.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,774.57 |
| Education | $64.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,555.08 | 2021-2025 | |
| Lilly USA, LLC | $1,114.38 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $761.48 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $758.04 | 2021-2025 | Ozempic, Rybelsus, Tresiba |
| Glaxosmithkline, LLC. | $649.93 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Pfizer INC. | $481.57 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $436.46 | 2021-2023 | Jardiance, Tradjenta, Synjardy |
| Astellas Pharma US INC | $285.21 | 2022-2024 | Veozah, Myrbetriq |
| Merck Sharp & Dohme LLC | $249.72 | 2021-2024 | Gardasil 9, Gardasil, Belsomra |
| Bayer Healthcare Pharmaceuticals INC. | $235.33 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $140.76 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $139.89 | 2021-2022 | |
| Esperion Therapeutics, INC. | $139.05 | 2021-2024 | Nexletol |
| Nestle Healthcare Nutrition INC. | $127.37 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $123.60 | 2021-2024 | Eliquis |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rhonda Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.